Tuesday, August 26th, 2025
Stock Profile: BJDX
BJDX Logo

Bluejay Diagnostics, Inc. (BJDX)

Market: NASD | Currency: USD

Address: 360 Massachusetts Avenue

Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers Symphony platform, a technology platform comprising Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. It also provides ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the company develops Symphony IL-6 test for the monitoring of disease progression in critical care settings. Further, it develops cardiac biomarkers, such as hsTNT and NT pro-BNP, as well as other tests using the Symphony platform. The company was incorporated in Show more




📈 Bluejay Diagnostics, Inc. Historical Chart






📊 Statistics





💰 Dividend History


Year Annual Yield (%) Total Amount Current Yield (%) Ex Date Pay Date Particulars
2024 - $0.020000 - 2024-11-18 - Stock split
$0.125000 - 2024-06-20 - Stock split
Total Amount for 2024: $0.145000
2023 - $0.050000 - 2023-07-24 - Stock split
Total Amount for 2023: $0.050000


📅 Earnings & EPS History for Bluejay Diagnostics, Inc.


DateReported EPS
2024-03-28-712
2023-11-09-832
2023-08-14-1100




📰 Related News & Research


No related articles found for "bluejay diagnostics".